Oxysterol Signatures Distinguish Age-Related Macular Degeneration from Physiologic Aging

被引:24
作者
Lin, Jonathan B. [1 ,2 ]
Sene, Abdoulaye [1 ]
Santeford, Andrea
Fujiwara, Hideji [3 ,4 ]
Sidhu, Rohini [3 ,4 ]
Ligon, Marianne M. [5 ]
Shankar, Vikram A. [1 ]
Ban, Norimitsu [1 ]
Mysorekar, Indira U. [5 ,6 ]
Ory, Daniel S. [3 ,4 ]
Apte, Rajendra S. [1 ,3 ,4 ,7 ]
机构
[1] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63130 USA
[2] Washington Univ, Sch Med, Div Biol & Biomed Sci, Neurosci Grad Program, St Louis, MO 63130 USA
[3] Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63130 USA
[4] Washington Univ, Sch Med, Dept Med, St Louis, MO 63130 USA
[5] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA
[6] Washington Univ, Sch Med, Ctr Reprod Hlth Sci, Dept Obstet & Gynecol, St Louis, MO 63130 USA
[7] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63130 USA
来源
EBIOMEDICINE | 2018年 / 32卷
关键词
Age-related macular degeneration; Aging; Lipids; Cholesterol; MACROPHAGE ACTIVATION; CHOLESTEROL EFFLUX; EXPRESSION; DISEASE; RISK; RANIBIZUMAB; AFLIBERCEPT; SENESCENCE; SEVERITY; ADULT;
D O I
10.1016/j.ebiom.2018.05.035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Macrophage aging is pathogenic in numerous diseases, including age-related macular degeneration (AMD), a leading cause of blindness in older adults. Although prior studies have explored the functional consequences of macrophage aging, less is known about its cellular basis or what defines the transition from physiologic aging to disease. Here, we showthat despite their frequent self-renewal, macrophages from old mice exhibited numerous signs of aging, such as impaired oxidative respiration. Transcriptomic profiling of aged murine macrophages revealed dysregulation of diverse cellular pathways, especially in cholesterol homeostasis, that manifested in altered oxysterol signatures. Although the levels of numerous oxysterols in human peripheral blood mononuclear cells and plasma exhibited age-associated changes, plasma 24-hydroxycholesterol levels were specifically associated with AMD. These novel findings demonstrate that oxysterol levels can discriminate disease from physiologic aging. Furthermore, modulation of cholesterol homeostasis may be a novel strategy for treating age-associated diseases in which macrophage aging is pathogenic. (C) 2018 The Authors. Published by Elsevier B.V.
引用
收藏
页码:9 / 20
页数:12
相关论文
共 50 条
  • [31] The Question of a Role for Statins in Age-Related Macular Degeneration
    Roizenblatt, Marina
    Naranjit, Nara
    Maia, Mauricio
    Gehlbach, Peter L.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)
  • [32] Exosome's Implications in Age-Related Macular Degeneration
    Torkashvand, Ali
    Hajrasouliha, Amir
    CURRENT EYE RESEARCH, 2025,
  • [33] Socioeconomic Costs of Age-related Macular Degeneration in Korea
    Ahn, Yongsun
    Jee, Donghyun
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2019, 60 (08): : 765 - 772
  • [34] Targeting Tissue Lipids in Age-related Macular Degeneration
    Apte, Rajendra S.
    EBIOMEDICINE, 2016, 5 : 26 - +
  • [35] An update on the pharmacotherapy of neovascular age-related macular degeneration
    Freund, K. Bailey
    Mrejen, Sarah
    Gallego-Pinazo, Roberto
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (08) : 1017 - 1028
  • [36] Dry Age-Related Macular Degeneration - Epidemiology and Classification
    Fleckenstein, Monika
    Thiele, Sarah
    Pfau, Maximilian
    Schmitz-Valckenberg, Steffen
    Holz, Frank G.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2019, 236 (09) : 1068 - 1075
  • [37] Variations in five genes and the severity of age-related macular degeneration: results from the Muenster aging and retina study
    Farwick, A.
    Dasch, B.
    Weber, B. H. F.
    Pauleikhoff, D.
    Stoll, M.
    Hense, H-W
    EYE, 2009, 23 (12) : 2238 - 2244
  • [38] AFLIBERCEPT FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Verner-Cole, E. A.
    Davis, S. J.
    Lauer, A. K.
    DRUGS OF TODAY, 2012, 48 (05) : 317 - 329
  • [39] Clinical safety of ranibizumab in age-related macular degeneration
    Schmidt-Erfurth, Ursula
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (01) : 149 - 165
  • [40] TACHYPHYLAXIS AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    Forooghian, Farzin
    Cukras, Catherine
    Meyerle, Catherine B.
    Chew, Emily Y.
    Wong, Wai T.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (06): : 723 - 731